Increased activity of cell membrane-associated prothrombinase, fibrinogen-like protein 2, in peripheral blood mononuclear cells of B-cell lymphoma patients

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Rabizadeh, Esther ^a,b   Cherny, Izhack ^a   Wolach, Ofir ^a,b   Sherman, Shany ^a,b   Binkovski, Natalia ^a   Peretz, Alon ^b   Lederfein, Doron ^a   Inbal, Aida ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; FIBRINOGEN LIKE PROTEIN 2; MESSENGER RNA; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; FGL2 PROTEIN, HUMAN; FIBRINOGEN; THROMBOPLASTIN;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER PATIENT; CANCER REGRESSION; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FGL 2 GENE; FOLLOW UP; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; REFERENCE VALUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; CELL MEMBRANE; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CELL MEMBRANE; FEMALE; FIBRINOGEN; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; THROMBOPLASTIN;

EID: 84907853312     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109648     Document Type: Article

References (26)

1. Blom JW, Osanto S, Rosendaal FR (2006) High risk of venous thrombosis in patients with pancreatic cancer: a cohort study of 202 patients. Eur J Cancer 42: 410-414.
2. Trousseau A (1865) In Clinique Medicale de l'Hotel-dieu de Paris. Phlegmasia Alba Dolens. Paris: JB Balliere et Fils: 654-715.
3. Blom JW, Doggen CJ, Osanto S, Rosendaal FR (2005) Malignancies, prothrombotic mutations, and the risk of venous thrombosis. Jama 293: 715-722.
4. Blom JW, Vanderschoot JP, Oostindier MJ, Osanto S, van der Meer FJ, et al. (2006) Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost 4: 529-535.
5. Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA (2000) Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343: 1846-1850.
6. Caruso V, Iacoviello L, Di Castelnuovo A, Storti S, Donati MB (2007) Venous thrombotic complications in adults undergoing induction treatment for acute lymphoblastic leukemia: results from a meta-analysis. J Thromb Haemost 5: 621-623.
7. Shankland KR, Armitage JO, Hancock BW (2012) Non-Hodgkin lymphoma. Lancet 380: 848-857.
8. Fisher SG, Fisher RI (2004) The epidemiology of non-Hodgkin's lymphoma. Oncogene 23: 6524-6534.
9. Smith A, Howell D, Patmore R, Jack A, Roman E (2011) Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. Br J Cancer 105: 1684-1692.
10. (1993) A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329: 987-994.
11. Geisler CH, Kolstad A, Laurell A, Raty R, Jerkeman M, et al. (2010) The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT). Blood 115: 1530-1533.
12. Solal-Celigny P (2006) Follicular Lymphoma International Prognostic Index. Curr Treat Options Oncol 7: 270-275.
13. Cheson BD (2005) Individualizing therapy for the hematologic malignancies: the stuff of genes and dreams. J Clin Oncol 23: 6283-6284.
14. Ning Q, Sun Y, Han M, Zhang L, Zhu C, et al. (2005) Role of fibrinogen-like protein 2 prothrombinase/fibroleukin in experimental and human allograft rejection. J Immunol 174: 7403-7411.
15. Su K, Chen F, Yan WM, Zeng QL, Xu L, et al. (2008) Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gamma. World J Gastroenterol 14: 5980-5989.
16. Chan CW, Chan MW, Liu M, Fung L, Cole EH, et al. (2002) Kinetic analysis of a unique direct prothrombinase, fgl2, and identification of a serine residue critical for the prothrombinase activity. J Immunol 168: 5170-5177.
17. Chan CW, Kay LS, Khadaroo RG, Chan MW, Lakatoo S, et al. (2003) Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells. J Immunol 170: 4036-4044.
18. Marazzi S, Blum S, Hartmann R, Gundersen D, Schreyer M, et al. (1998) Characterization of human fibroleukin, a fibrinogen-like protein secreted by T lymphocytes. J Immunol 161: 138-147.
19. Ruegg C, Pytela R (1995) Sequence of a human transcript expressed in T-lymphocytes and encoding a fibrinogen-like protein. Gene 160: 257-262.
20. Ghanekar A, Mendicino M, Liu H, He W, Liu M, et al. (2004) Endothelial induction of fgl2 contributes to thrombosis during acute vascular xenograft rejection. J Immunol 172: 5693-5701.
21. Hancock WW, Szaba FM, Berggren KN, Parent MA, Mullarky IK, et al. (2004) Intact type 1 immunity and immune-associated coagulative responses in mice lacking IFN gamma-inducible fibrinogen-like protein 2. Proc Natl Acad Sci U S A 101: 3005-3010.
22. Liu Y, Xu L, Zeng Q, Wang J, Wang M, et al. (2012) Downregulation of FGL2/prothrombinase delays HCCLM6 xenograft tumour growth and decreases tumour angiogenesis. Liver Int 32: 1585-1595.
23. Huijgen HJ, Sanders GT, Koster RW, Vreeken J, Bossuyt PM (1997) The clinical value of lactate dehydrogenase in serum: a quantitative review. Eur J Clin Chem Clin Biochem 35: 569-579.
24. El-Sharkawi D, Basu S, Ocampo C, Qian W, D'Sa S, et al. (2012) Elevated lactate dehydrogenase levels detected during routine follow-up do not predict relapse in patients with diffuse large B-cell lymphoma who achieve complete remission after primary treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone-like immunochemotherapy. Leuk Lymphoma 53: 1949-1952.
25. Martelli M, Ferreri AJ, Agostinelli C, Di Rocco A, Pfreundschuh M, et al. (2013) Diffuse large B-cell lymphoma. Crit Rev Oncol Hematol 87: 146-171.
26. Gry M, Rimini R, Stromberg S, Asplund A, Ponten F, et al. (2009) Correlations between RNA and protein expression profiles in 23 human cell lines. BMC Genomics 10: 365.